Síðkomnar og langvinnar aukaverkanir eftir hvítblæðismeðferð í æsku

Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/Open Introduction: The treatment of childhood leukemia has improved substantially over the last decades and now 65-75% of the patients recover. With increasing number of survivors it is important to know the...

Full description

Bibliographic Details
Main Authors: Valur Helgi Kristinsson, Jón R. Kristinsson, Guðmundur Kr. Jónmundsson, Ólafur Gísli Jónsson, Árni V. Þórsson, Ásgeir Haraldsson
Format: Article in Journal/Newspaper
Language:Icelandic
Published: Læknafélag Íslands, Læknafélag Reykjavíkur 2008
Subjects:
Online Access:http://hdl.handle.net/2336/16314
id ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/16314
record_format openpolar
spelling ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/16314 2023-05-15T16:48:03+02:00 Síðkomnar og langvinnar aukaverkanir eftir hvítblæðismeðferð í æsku Late and long-term effects of leukaemia treatment in childhood Valur Helgi Kristinsson Jón R. Kristinsson Guðmundur Kr. Jónmundsson Ólafur Gísli Jónsson Árni V. Þórsson Ásgeir Haraldsson 2008-01-18 http://hdl.handle.net/2336/16314 ICE is ice Læknafélag Íslands, Læknafélag Reykjavíkur http://www.laeknabladid.is/2002/1/fraedigreinar/nr/724/ Læknablaðið 2002, 88(1):13-8 0023-7213 16940660 http://hdl.handle.net/2336/16314 Læknablaðið Aukaverkanir Börn Hvítblæði Krabbamein Meðferð LBL12 Leukemia Child Article 2008 ftlandspitaliuni 2022-05-29T08:21:04Z Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/Open Introduction: The treatment of childhood leukemia has improved substantially over the last decades and now 65-75% of the patients recover. With increasing number of survivors it is important to know the long-term and late effects of leukemia and leukaemia treatment. Patients: Of the 31 children diagnosed with leukemia in Iceland from 1981 to 1990, twenty were enrolled in the study. Average age at enrollment was16 years and 8 months (16:8) and average time since treatment ended was 8:3. Methods: The study was carried out at the Children's Hospital at the University Hospital Iceland where patients were examined and data was gathered on height, weight, hearing, cognitive functions, bloodvalues, immunoglobulins and renal, endocrine, heart, liver and respiratory functions. Results: The children studied were on average 0.48 standard deviations below target height and their body-mass index was higher at the time of study than at diagnosis. Two children had obvious obstructive lung disease. No abnormalities were found in complete blood count nor heart, liver or kidney functions. Two patients were found to have impaired hearing not attributable to acoustic trauma. In some cases abnormal values were found in immunoglobulin classes and 12 patients had decreased serum IgG2. Six needed remedial reading lessons. Three patients needed hormone replacement therapy. Discussion: Minor impact on height and weight was found but the effects on lungs and hearing were inconclusive. Despite markedly decreased serum IgG2 the patients were not more prone to infections. The most obvious effects were on the endocrine system and performance at school. We conclude that the sequelae of childhood leukemia treatment in Iceland are significant and long-lasting, underlining the necessity of a careful long-term follow-up. Inngangur: Fyrir 30 árum var hvítblæði í flestum tilvikum banvænn sjúkdómur í börnum. Síðan þá hefur árangur meðferðar batnað til ... Article in Journal/Newspaper Iceland Hirsla - Landspítali University Hospital research archive Smella ENVELOPE(29.443,29.443,69.896,69.896)
institution Open Polar
collection Hirsla - Landspítali University Hospital research archive
op_collection_id ftlandspitaliuni
language Icelandic
topic Aukaverkanir
Börn
Hvítblæði
Krabbamein
Meðferð
LBL12
Leukemia
Child
spellingShingle Aukaverkanir
Börn
Hvítblæði
Krabbamein
Meðferð
LBL12
Leukemia
Child
Valur Helgi Kristinsson
Jón R. Kristinsson
Guðmundur Kr. Jónmundsson
Ólafur Gísli Jónsson
Árni V. Þórsson
Ásgeir Haraldsson
Síðkomnar og langvinnar aukaverkanir eftir hvítblæðismeðferð í æsku
topic_facet Aukaverkanir
Börn
Hvítblæði
Krabbamein
Meðferð
LBL12
Leukemia
Child
description Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/Open Introduction: The treatment of childhood leukemia has improved substantially over the last decades and now 65-75% of the patients recover. With increasing number of survivors it is important to know the long-term and late effects of leukemia and leukaemia treatment. Patients: Of the 31 children diagnosed with leukemia in Iceland from 1981 to 1990, twenty were enrolled in the study. Average age at enrollment was16 years and 8 months (16:8) and average time since treatment ended was 8:3. Methods: The study was carried out at the Children's Hospital at the University Hospital Iceland where patients were examined and data was gathered on height, weight, hearing, cognitive functions, bloodvalues, immunoglobulins and renal, endocrine, heart, liver and respiratory functions. Results: The children studied were on average 0.48 standard deviations below target height and their body-mass index was higher at the time of study than at diagnosis. Two children had obvious obstructive lung disease. No abnormalities were found in complete blood count nor heart, liver or kidney functions. Two patients were found to have impaired hearing not attributable to acoustic trauma. In some cases abnormal values were found in immunoglobulin classes and 12 patients had decreased serum IgG2. Six needed remedial reading lessons. Three patients needed hormone replacement therapy. Discussion: Minor impact on height and weight was found but the effects on lungs and hearing were inconclusive. Despite markedly decreased serum IgG2 the patients were not more prone to infections. The most obvious effects were on the endocrine system and performance at school. We conclude that the sequelae of childhood leukemia treatment in Iceland are significant and long-lasting, underlining the necessity of a careful long-term follow-up. Inngangur: Fyrir 30 árum var hvítblæði í flestum tilvikum banvænn sjúkdómur í börnum. Síðan þá hefur árangur meðferðar batnað til ...
format Article in Journal/Newspaper
author Valur Helgi Kristinsson
Jón R. Kristinsson
Guðmundur Kr. Jónmundsson
Ólafur Gísli Jónsson
Árni V. Þórsson
Ásgeir Haraldsson
author_facet Valur Helgi Kristinsson
Jón R. Kristinsson
Guðmundur Kr. Jónmundsson
Ólafur Gísli Jónsson
Árni V. Þórsson
Ásgeir Haraldsson
author_sort Valur Helgi Kristinsson
title Síðkomnar og langvinnar aukaverkanir eftir hvítblæðismeðferð í æsku
title_short Síðkomnar og langvinnar aukaverkanir eftir hvítblæðismeðferð í æsku
title_full Síðkomnar og langvinnar aukaverkanir eftir hvítblæðismeðferð í æsku
title_fullStr Síðkomnar og langvinnar aukaverkanir eftir hvítblæðismeðferð í æsku
title_full_unstemmed Síðkomnar og langvinnar aukaverkanir eftir hvítblæðismeðferð í æsku
title_sort síðkomnar og langvinnar aukaverkanir eftir hvítblæðismeðferð í æsku
publisher Læknafélag Íslands, Læknafélag Reykjavíkur
publishDate 2008
url http://hdl.handle.net/2336/16314
long_lat ENVELOPE(29.443,29.443,69.896,69.896)
geographic Smella
geographic_facet Smella
genre Iceland
genre_facet Iceland
op_relation http://www.laeknabladid.is/2002/1/fraedigreinar/nr/724/
Læknablaðið 2002, 88(1):13-8
0023-7213
16940660
http://hdl.handle.net/2336/16314
Læknablaðið
_version_ 1766038143957467136